1.
Cardiol Clin
; 31(4): 533-44, viii, 2013 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24188219
RESUMO
This article reviews the pivotal studies of several novel antiplatelet (prasugrel and ticagrelor) and anticoagulant (dabigatran, rivaroxaban, and apixaban) agents. The clinical use of these drugs in cardiac intensive care is discussed, focusing on the management of acute coronary syndromes, ischemic stroke, atrial fibrillation, and venous thromboembolism.